A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease
Clinical trial NCT03084796 · COMPLETED
Trial details
- NCT number
- NCT03084796
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2018-05-23
- Enrollment
- 733
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.